chr10-122514155-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002775.5(HTRA1):​c.1275-36C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.194 in 1,605,236 control chromosomes in the GnomAD database, including 33,858 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.18 ( 2928 hom., cov: 31)
Exomes 𝑓: 0.20 ( 30930 hom. )

Consequence

HTRA1
NM_002775.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.246

Publications

15 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 0 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-122514155-C-T is Benign according to our data. Variant chr10-122514155-C-T is described in ClinVar as Benign. ClinVar VariationId is 1259856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.402 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTRA1NM_002775.5 linkc.1275-36C>T intron_variant Intron 8 of 8 ENST00000368984.8 NP_002766.1 Q92743

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTRA1ENST00000368984.8 linkc.1275-36C>T intron_variant Intron 8 of 8 1 NM_002775.5 ENSP00000357980.3 Q92743
HTRA1ENST00000648167.1 linkc.957-36C>T intron_variant Intron 8 of 8 ENSP00000498033.1 A0A3B3IU24
HTRA1ENST00000420892.1 linkc.498-36C>T intron_variant Intron 5 of 5 2 ENSP00000412676.1 H0Y7G9

Frequencies

GnomAD3 genomes
AF:
0.185
AC:
28057
AN:
151920
Hom.:
2927
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.332
Gnomad AMR
AF:
0.211
Gnomad ASJ
AF:
0.218
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.366
Gnomad FIN
AF:
0.126
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.209
GnomAD2 exomes
AF:
0.221
AC:
55644
AN:
251330
AF XY:
0.230
show subpopulations
Gnomad AFR exome
AF:
0.141
Gnomad AMR exome
AF:
0.188
Gnomad ASJ exome
AF:
0.228
Gnomad EAS exome
AF:
0.432
Gnomad FIN exome
AF:
0.133
Gnomad NFE exome
AF:
0.185
Gnomad OTH exome
AF:
0.206
GnomAD4 exome
AF:
0.195
AC:
283440
AN:
1453198
Hom.:
30930
Cov.:
29
AF XY:
0.201
AC XY:
145665
AN XY:
723596
show subpopulations
African (AFR)
AF:
0.144
AC:
4789
AN:
33288
American (AMR)
AF:
0.191
AC:
8533
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
5941
AN:
26076
East Asian (EAS)
AF:
0.433
AC:
17166
AN:
39652
South Asian (SAS)
AF:
0.370
AC:
31824
AN:
86038
European-Finnish (FIN)
AF:
0.134
AC:
7136
AN:
53382
Middle Eastern (MID)
AF:
0.237
AC:
1201
AN:
5062
European-Non Finnish (NFE)
AF:
0.176
AC:
194319
AN:
1104980
Other (OTH)
AF:
0.209
AC:
12531
AN:
59998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
12832
25664
38496
51328
64160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6988
13976
20964
27952
34940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.185
AC:
28070
AN:
152038
Hom.:
2928
Cov.:
31
AF XY:
0.188
AC XY:
13962
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.143
AC:
5916
AN:
41446
American (AMR)
AF:
0.211
AC:
3224
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.218
AC:
757
AN:
3472
East Asian (EAS)
AF:
0.417
AC:
2153
AN:
5166
South Asian (SAS)
AF:
0.366
AC:
1758
AN:
4802
European-Finnish (FIN)
AF:
0.126
AC:
1332
AN:
10572
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.178
AC:
12108
AN:
67990
Other (OTH)
AF:
0.212
AC:
449
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1124
2248
3373
4497
5621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.177
Hom.:
1835
Bravo
AF:
0.189
Asia WGS
AF:
0.345
AC:
1204
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 23, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31603204, 30859180) -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CARASIL syndrome Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.0
DANN
Benign
0.44
PhyloP100
-0.25
BranchPoint Hunter
0.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293871; hg19: chr10-124273671; COSMIC: COSV64563219; API